Drugs.com - FDA MedWatch Alerts

Aurobindo Pharma USA, Inc. on Behalf of AuroHealth, Issues Recall of One Lot of Healthy Living Over the Counter (OTC) Migraine Relief

Audience: Healthcare Provider, Pharmacy, Consumer July 18, 2024 – East Windsor, New Jersey. Aurobindo Pharma USA, Inc., on behalf of AuroHealth, is voluntarily recalling one lot (refer table below) of Healthy Living Migraine Relief...

Feb 9, 2025 - 21:45
 0
Aurobindo Pharma USA, Inc. on Behalf of AuroHealth, Issues Recall of One Lot of Healthy Living Over the Counter (OTC) Migraine Relief
Audience: Healthcare Provider, Pharmacy, Consumer July 18, 2024 – East Windsor, New Jersey. Aurobindo Pharma USA, Inc., on behalf of AuroHealth, is voluntarily recalling one lot (refer table below) of Healthy Living Migraine Relief...
Read More

Tags:

Previous Article

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of One Lot of...

Next Article

GURU INC. Issues Voluntary Nationwide Recall of Infla-650 Herbal Dietary Supplem...

Related Posts

FDA Warns Consumers Not to Use Counterfeit Ozempic (semaglutide) Found in U.S. Drug Supply Chain

FDA Warns Consumers Not to Use Counterfeit Ozempic (sem...

Apr 15, 2025  0

Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Bacterial Contamination

Bionpharma Inc. Issues Voluntary Nationwide Recall of A...

Feb 9, 2025  0

Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors

Endo USA, Inc. Issues Voluntary, Nationwide Recall of A...

Feb 9, 2025  0